UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055919
Receipt number R000063899
Scientific Title A Prospective Observational Study Evaluating Lung Drug Clearance Using Isosorbide Dinitrate as a Probe.
Date of disclosure of the study information 2024/10/23
Last modified on 2024/12/21 10:25:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Observational Study Evaluating Lung Drug Clearance Using Isosorbide Dinitrate as a Probe.

Acronym

A Prospective Observational Study Evaluating Lung Drug Clearance Using Isosorbide Dinitrate as a Probe.

Scientific Title

A Prospective Observational Study Evaluating Lung Drug Clearance Using Isosorbide Dinitrate as a Probe.

Scientific Title:Acronym

A Prospective Observational Study Evaluating Lung Drug Clearance Using Isosorbide Dinitrate as a Probe.

Region

Japan


Condition

Condition

Patients scheduled for both heart catheterization and endomyocardial biopsy, with planned use of isosorbide dinitrate (ISDN) During the Procedure.

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether isosorbide dinitrate is cleared in the lungs.

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Insantaneous Extraction Ratio (ER) of Isosorbide Dinitrate in the lung.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients scheduled for both heart catheterization and endomyocardial biopsy
Patients planned to have a sheath placed in the radial artery
Patients expected to receive 1.0 mg or more of isosorbide dinitrate injection (5 mg/10 mL) during coronary angiography.
Individuals aged 18 years or older and 85 years or younger at the time of consent
Patients with a BMI (Body Mass Index) of 18.0 kg/m2 or higher and 35.0 kg/m2 or lower at screening.
Patients who have provided written consent

Key exclusion criteria

AST and ALT levels exceeding three times the upper limit of normal values.
Serum creatinine levels exceeding 1.5 times the upper limit of normal values.
Requirement for continuous oxygen therapy due to pulmonary disease.
Decompensated heart failure at the time of consent.
Patients diagnosed with severe valvular disease by echocardiography.
Deemed unsuitable for this study by the investigator.

Exclusion Criteria for Lab Values Obtained During Cardiac Catheterization

Cardiac Index (CI) obtained by the thermodilution method is 1.8 L/min/m2 or below.
Pulmonary Artery Wedge Pressure (PAWP) is 18 mmHg or higher.
Pulmonary Vascular Resistance (PVR) calculated as (mean PAP - PAWP) / CO is 3.0 Wood or higher, or mean PAP is 25 mmHg or higher.
A sheath could not be placed in the radial artery.
The physician deems the administration of Isosorbide Dinitrate inappropriate due to reasons such as hypotension.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Naoto
Middle name
Last name Uemura

Organization

Oita University

Division name

Department of Clinical Pharmacology and Therapeutics

Zip code

8795593

Address

1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593 Japan

TEL

0975865952

Email

khayashi@oita-u.ac.jp


Public contact

Name of contact person

1st name Kosuke
Middle name
Last name Hayashi

Organization

Oita University

Division name

Department of Clinical Pharmacology and Therapeutics

Zip code

8795593

Address

1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593 Japan

TEL

0975865952

Homepage URL


Email

khayashi@oita-u.ac.jp


Sponsor or person

Institute

Oita University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI Grant Number 22K06701

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagoya City University Department of Cardiology

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Oita University Ethics Committee

Address

1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593 Japan

Tel

0975865952

Email

rinrikenkyu@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 07 Month 12 Day

Date of IRB

2024 Year 08 Month 28 Day

Anticipated trial start date

2024 Year 10 Month 28 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2024 Year 10 Month 22 Day

Last modified on

2024 Year 12 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063899